Literature DB >> 23616316

Unravelling the Gordian knot: diagnostic dilemma in an HIV-positive patient with neurological involvement.

Avirup Chakraborty1, Sattik Siddhanta, Kuntal Bhattacharyya, Amit Das, Siwalik Banerjee, Rathindra Nath Sarkar, Utpal Kumar Datta, Nilanjan Chakraborty.   

Abstract

We report a case of a 40-year-old seropositive-HIV patient with a CD4 count of 120 who presented with fever, severe headache and neck stiffness. Suspecting a case of tubercular meningitis (TBM; as tuberculosis is the commonest opportunistic infection in HIV/AIDS patients in India), a lumbar puncture was performed and a cerebrospinal fluid study revealed TBM. The patient was started on combination antitubercular drug therapy from directly observed treatment, short course (DOTS) (Cat 1 regimen) along with pyridoxine 40 mg/day and adjunctive corticosteroid therapy. However, despite adequate antitubercular therapy for 4 weeks, the patient did not show any improvement in his clinical condition. On the contrary, in the process he developed cytomegalovirus (CMV) retinitis. So we question our learned readers if the coinfection of Mycobacterium tuberculosis and CMV should be implicated for the failure to respond to isolated antitubercular therapy contrary to our expectation.

Entities:  

Mesh:

Year:  2013        PMID: 23616316      PMCID: PMC3644930          DOI: 10.1136/bcr-2012-008524

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection.

Authors:  S M Katrak; P K Shembalkar; S R Bijwe; L D Bhandarkar
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

2.  Mortality associated with central nervous system tuberculosis.

Authors:  Hana M El Sahly; Larry D Teeter; Xi Pan; James M Musser; Edward A Graviss
Journal:  J Infect       Date:  2007-10-17       Impact factor: 6.072

3.  Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome.

Authors:  S K Bandyopadhyay; R Bandyopadhyay; A Dutta
Journal:  West Indian Med J       Date:  2009-12       Impact factor: 0.171

Review 4.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.

Authors:  J R Deayton; P Wilson; C A Sabin; C C Davey; M A Johnson; V C Emery; P D Griffiths
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Authors:  Guy E Thwaites; Duc Bang Nguyen; Huy Dung Nguyen; Thi Quy Hoang; Thi Tuong Oanh Do; Thi Cam Thoa Nguyen; Quang Hien Nguyen; Tri Thuc Nguyen; Ngoc Hai Nguyen; Thi Ngoc Lan Nguyen; Ngoc Lan Nguyen; Hong Duc Nguyen; Ngoc Tuan Vu; Huu Hiep Cao; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Kasia Stepniewska; Nicholas J White; Tinh Hien Tran; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

Review 7.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 8.  Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.

Authors:  A D Harries; R Zachariah; S D Lawn
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

Review 9.  Posterior segment manifestations of HIV/AIDS.

Authors:  Tamara R Vrabec
Journal:  Surv Ophthalmol       Date:  2004 Mar-Apr       Impact factor: 6.048

Review 10.  Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

Authors:  Petros I Rafailidis; Eleni G Mourtzoukou; Ioannis C Varbobitis; Matthew E Falagas
Journal:  Virol J       Date:  2008-03-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.